Endothelins and Asthma

Roy Goldie, Peter Henry

Research output: Contribution to journalArticlepeer-review

57 Citations (Scopus)


In the decade since endothelin-1 (ET-1) and related endogenous peptides were first identified as vascular endothelium-derived spasmogens, with potential pathophysiological roles in vascular diseases, there has been a significant accumulation of evidence pointing to mediator roles in obstructive respiratory diseases such as asthma. Critical pieces of evidence for this concept include the fact that ET-1 is an extremely potent spasmogen in human and animal airway smooth muscle and that it is synthesised in and released from the bronchial epithelium. Importantly, symptomatic asthma involves a marked enhancement of these processes, whereas asthmatics treated with anti-inflammatory glucocorticoids exhibit reductions in these previously elevated indices. Despite this profile, a causal link between ET-1 and asthma has not been definitively established. This review attempts to bring together some of the evidence suggesting the potential mediator roles for ET-1 in this disease.
Original languageEnglish
Pages (from-to)1-15
JournalLife Sciences
Issue numberNo 1
Publication statusPublished - 1999


Dive into the research topics of 'Endothelins and Asthma'. Together they form a unique fingerprint.

Cite this